BiotechTube
Lunaphore Technologies

Lunaphore Technologies

Lausanne, Switzerland· Est.
lunaphore.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $68M

Overview

Lunaphore Technologies is a pioneering spatial biology company that has developed a unique, chip-based microfluidic platform to automate and accelerate hyperplex tissue analysis. Its flagship COMET™ system utilizes proprietary Fast Fluidic Exchange (FFeX™) and sequential immunofluorescence (seqIF™) technologies to enable rapid, uniform, and reproducible staining of dozens of biomarkers on a single tissue slide. The company targets the rapidly growing research and translational markets, with an open and flexible system designed to democratize spatial biology, and has established key partnerships to expand its technological reach. While currently focused on research, Lunaphore's long-term vision includes developing tools that pave the way to clinical diagnostics.

OncologyNeuroscienceInfectious Disease

Technology Platform

Proprietary microfluidic chip enabling Fast Fluidic Exchange (FFeX™) for rapid reagent incubation and sequential immunofluorescence (seqIF™) for automated, conjugation-free hyperplex tissue imaging. Integrated with automated imaging (COMET™) and analysis software (HORIZON™).

Funding History

3
Total raised:$68M
Series C$40M
Series B$20M
Series A$8M

Opportunities

The spatial biology market is experiencing rapid growth driven by demand in immuno-oncology and drug development.
Lunaphore's automated, open-platform approach addresses key adoption barriers of complexity and time, positioning it to capture share in the translational research market and build a pathway toward future clinical diagnostic applications.

Risk Factors

Faces intense competition from established and emerging spatial biology companies.
Market adoption of new capital equipment can be slow, and scaling a global commercial operation presents execution challenges.
The long-term goal of entering the clinical market introduces significant regulatory and validation hurdles.

Competitive Landscape

Lunaphore competes in the spatial proteomics market against companies like Akoya Biosciences (PhenoCycler, PhenoImager), NanoString (GeoMx DSP, CosMx SMI), and 10x Genomics (Visium, Xenium). Its differentiation lies in full automation, rapid cycle times using standard antibodies, and an open, flexible system designed for ease of use and scalability in research settings.

More companies in Switzerland →